Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

Clinical trial NCT02101593 · COMPLETED

Trial details

NCT number: NCT02101593
Sponsor: Polaris Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2014-11-01
Primary completion: 2016-02-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.